Huntington Ingalls Industries Inc
Change company Symbol lookup
Select an option...
HII Huntington Ingalls Industries Inc
BABA Alibaba Group Holding Ltd
ABBV Abbvie Inc
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
AGNC Agnc Investment Corp
GME GameStop Corp

Industrials : Aerospace & Defense | Mid Cap Value
Company profile

Huntington Ingalls Industries, Inc. is a military shipbuilding company and a provider of professional services to partners in government and industry. The Company's business consists of the design, construction, repair and maintenance of nuclear-powered ships and non-nuclear ships for the United States Navy and coastal defense surface ships for the United States Coast Guard, as well as the refueling and overhaul and inactivation of nuclear-powered ships for the United States Navy. It operates through three segments: Ingalls Shipbuilding (Ingalls), Newport News Shipbuilding (Newport News) and Technical Solutions. Its Ingalls segment includes its non-nuclear ship design, construction, repair and maintenance businesses. Its Newport News includes all of its nuclear ship design, construction, overhaul, refueling, and repair and maintenance businesses. Its Technical Solutions segment provides a range of professional services to the governmental and energy markets.

Closing Price
Day's Change
-0.29 (-0.14%)
B/A Size
Day's High
Day's Low

10-day average volume:

BioHiTech stock rockets after expanded relationship with Carnival, and new purchase orders

8:33 am ET March 18, 2021 (MarketWatch)

Shares of BioHiTech Global Inc. (BHTG) rocketed 41.5% to pace all premarket gainers in active trading Thursday, after the waste management company said it has expanded its relationship with cruise operator Carnival Corp. (CCL), including the coverage of fifteen additional cruise ships. Trading volume swelled to 7.9 million shares, compared with the full-day average of about 2.3 million shares over the past 30 days. Carnival's stock rose 2.1% ahead of the open. BioHiTech said it recently received purchase orders for more than $1.8 million worth of food digesters, which the company expects to fulfill during the second and third quarters of 2021. The company had recorded a total of $2.0 million in revenue over the second and third quarters of 2020. BioHiTech's stock has run up 55.4% over the past three months through Wednesday, while the S&P 500 has gained 7.1%.

-Tomi Kilgore; 415-439-6400;


(END) Dow Jones Newswires

March 18, 2021 08:33 ET (12:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.